Premerus Issues Study Addressing Medical Misdiagnosis in America 2008
Premerus, the nation’s only company dedicated to advancing clinical accuracy through diagnostic excellence, released a white paper which documents the problems of medical misdiagnosis, defines the specific challenges to health plans, benefits payers and consumers and offers solutions
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies